Wednesday Apr 16
Cramer's Lightning Round - I Was Too Bullish On LinkedIn
Teva Pharmaceuticals : "Sell half...I'm not so worried about its Copaxone drug. So why sell half at all? Because you have made a great profit and the market is uncertain."
Trending on the Topix Network
Tue Apr 15, 2014
Arena Pharmaceuticals Director Sells $217,700 in Stock
Arena Pharmaceuticals Director Tina Susan Nova sold 35,000 shares of the stock on the open market in a transaction dated Monday, April 14th.
Mon Apr 14, 2014
Applied Clinical Trials
Arena Pharmaceuticals Reports Eisai's Launch of National Television...
Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ? CIV for Chronic Weight Management Arena Pharmaceuticals Reports Eisai's Launch of National Television Advertising Campaign for BELVIQ CIV for Chronic Weight Management /PRNewswire/ -- Arena Pharmaceuticals, Inc. today reported that Eisai Inc. has ... (more)
Fri Apr 11, 2014
Arena - Belviq Sales Up Modestly Heading Into Television Ads
It is certainly an interesting time to be an investor in Arena Pharmaceuticals .
Fri Apr 04, 2014
Arena Script Sales Close Out Quarter On Positive Note
Sales of the Arena Pharmaceuticals anti-obesity drug Belviq have closed out the quarter on a positive note.
Wed Apr 02, 2014
Arena Pharmaceuticals Director Donald D. Belcher Unloads 1,905 Shares
Arena Pharmaceuticals Director Donald D. Belcher sold 1,905 shares of Arena Pharmaceuticals stock in a transaction dated Tuesday, April 1st.
Insider Selling: William R. Shanahan, Jr. Unloads 60,000 Shares of Arena Pharmaceuticals Stock
Arena Pharmaceuticals SVP William R. Shanahan, Jr. unloaded 60,000 shares of the company's stock on the open market in a transaction that occurred on Tuesday, April 1st.
Tue Apr 01, 2014
Arena Pharmaceuticals Sees Large Decrease in Short Interest
Arena Pharmaceuticals saw a significant decrease in short interest during the month of January.
Mon Mar 31, 2014
The Motley Fool
Can Arena and VIVUS Profit From Glaxo's Troubles?
The drug remains on the shelf in Europe, where there doesn't seem to be a problem.